These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 38683365)

  • 1. Interplay between α-synuclein and parkin genes: Insights of Parkinson's disease.
    Sharma K; Chib S; Gupta A; Singh R; Chalotra R
    Mol Biol Rep; 2024 Apr; 51(1):586. PubMed ID: 38683365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular chaperones and Parkinson's disease.
    Hu S; Tan J; Qin L; Lv L; Yan W; Zhang H; Tang B; Wang C
    Neurobiol Dis; 2021 Dec; 160():105527. PubMed ID: 34626793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interplay between parkin and alpha-synuclein; possible implications for the pathogenesis of Parkinson's disease.
    Jęśko H; Lenkiewicz AM; Wilkaniec A; Adamczyk A
    Acta Neurobiol Exp (Wars); 2019; 79(3):276-289. PubMed ID: 31587020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease.
    Yasuda T; Mochizuki H
    Apoptosis; 2010 Nov; 15(11):1312-21. PubMed ID: 20221696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trib3 Is Elevated in Parkinson's Disease and Mediates Death in Parkinson's Disease Models.
    Aimé P; Sun X; Zareen N; Rao A; Berman Z; Volpicelli-Daley L; Bernd P; Crary JF; Levy OA; Greene LA
    J Neurosci; 2015 Jul; 35(30):10731-49. PubMed ID: 26224857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
    Sharma N; Rao SP; Kalivendi SV
    Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Overcrowded Crossroads: Mitochondria, Alpha-Synuclein, and the Endo-Lysosomal System Interaction in Parkinson's Disease.
    Lin KJ; Lin KL; Chen SD; Liou CW; Chuang YC; Lin HY; Lin TK
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31731450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of parkin causes neurodegeneration and accumulation of pathological α-synuclein in monkey models.
    Han R; Wang Q; Xiong X; Chen X; Tu Z; Li B; Zhang F; Chen C; Pan M; Xu T; Chen L; Wang Z; Liu Y; He D; Guo X; He F; Wu P; Yin P; Liu Y; Yan X; Li S; Li XJ; Yang W
    J Clin Invest; 2024 Oct; 134(20):. PubMed ID: 39403921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular delivery of Parkin rescues neurons from accumulation of damaged mitochondria and pathological α-synuclein.
    Chung E; Choi Y; Park J; Nah W; Park J; Jung Y; Lee J; Lee H; Park S; Hwang S; Kim S; Lee J; Min D; Jo J; Kang S; Jung M; Lee PH; Ruley HE; Jo D
    Sci Adv; 2020 May; 6(18):eaba1193. PubMed ID: 32494688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease.
    Lo Bianco C; Schneider BL; Bauer M; Sajadi A; Brice A; Iwatsubo T; Aebischer P
    Proc Natl Acad Sci U S A; 2004 Dec; 101(50):17510-5. PubMed ID: 15576511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of heat shock proteins and parkin/α-synuclein axis in Parkinson's disease.
    Aghazadeh N; Beilankouhi EAV; Fakhri F; Gargari MK; Bahari P; Moghadami A; Khodabandeh Z; Valilo M
    Mol Biol Rep; 2022 Nov; 49(11):11061-11070. PubMed ID: 36097120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell infiltration and upregulation of MHCII in microglia leads to accelerated neuronal loss in an α-synuclein rat model of Parkinson's disease.
    Subbarayan MS; Hudson C; Moss LD; Nash KR; Bickford PC
    J Neuroinflammation; 2020 Aug; 17(1):242. PubMed ID: 32799878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial dysfunction in genetic animal models of Parkinson's disease.
    Trancikova A; Tsika E; Moore DJ
    Antioxid Redox Signal; 2012 May; 16(9):896-919. PubMed ID: 21848447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peiminine Reduces ARTS-Mediated Degradation of XIAP by Modulating the PINK1/Parkin Pathway to Ameliorate 6-Hydroxydopamine Toxicity and α-Synuclein Accumulation in Parkinson's Disease Models In Vivo and In Vitro.
    Hsu YL; Hung HS; Tsai CW; Liu SP; Chiang YT; Kuo YH; Shyu WC; Lin SZ; Fu RH
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nigral overexpression of alpha-synuclein in the absence of parkin enhances alpha-synuclein phosphorylation but does not modulate dopaminergic neurodegeneration.
    Van Rompuy AS; Oliveras-Salvá M; Van der Perren A; Corti O; Van den Haute C; Baekelandt V
    Mol Neurodegener; 2015 Jun; 10():23. PubMed ID: 26099628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surprising behavioral and neurochemical enhancements in mice with combined mutations linked to Parkinson's disease.
    Hennis MR; Marvin MA; Taylor CM; Goldberg MS
    Neurobiol Dis; 2014 Feb; 62():113-23. PubMed ID: 24075852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
    Perfeito R; Cunha-Oliveira T; Rego AC
    Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common Mechanisms Underlying α-Synuclein-Induced Mitochondrial Dysfunction in Parkinson's Disease.
    Sohrabi T; Mirzaei-Behbahani B; Zadali R; Pirhaghi M; Morozova-Roche LA; Meratan AA
    J Mol Biol; 2023 Jun; 435(12):167992. PubMed ID: 36736886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
    Büeler H
    Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinson's disease in a dish - Using stem cells as a molecular tool.
    Badger JL; Cordero-Llana O; Hartfield EM; Wade-Martins R
    Neuropharmacology; 2014 Jan; 76 Pt A():88-96. PubMed ID: 24035919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.